Practical Considerations for Nadofaragene Firadenovec Use e firadenovec, including administration, monitoring, supportive care, and patient education. Successful instillation of nadofaragene fir …

Find information on the dosing and administration of ADSTILADRIN®, including instillation details. See Important Safety Info.

11 DESCRIPTION ADSTILADRIN (nadofaragene firadenovec-vncg) is a non-replicating adenoviral vector-based gene therapy for intravesical instillation.

Oct 10, 2025 · Detailed dosage guidelines and administration information for Adstiladrin (nadofaragene firadenovec-vncg). Includes dose adjustments, warnings and precautions.

Jun 26, 2025 · Abstract Purpose: Nadofaragene firadenovec-vncg is a US Food and Drug Administration-approved therapy for bacillus Calmette-Guérin-unresponsive nonmuscle-invasive …

Description/Mechanism of Action • Nadofaragene firadenovec is a non-replicating adenoviral vector-based gene therapy for bladder instillation. The replication-deficient adenovirus vector contains a …

Nov 26, 2025 · Sam Chang speaks with Laura Bukavina and Betty Wang about a plain language summary for nadofaragene firadenovec use in BCG-unresponsive bladder cancer. Dr. Wang …

Feb 17, 2025 · Pharmacist roles in a multidisciplinary care team are described and involve considerations surrounding nadofaragene firadenovec, including its mechanism of action, indication, …

ADSTILADRIN® is the first and only FDA-approved intravesical gene therapy for patients with high-risk BCG-unresponsive NMIBC. See Important Safety Info.

Nadofaragene firadenovec, sold under the brand name Adstiladrin, is a gene therapy for the treatment of bladder cancer. [1][3][4] It is a non-replicating (cannot multiply in human cells) adenoviral vector …